Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...
FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
In this study, researchers matched patients using GLP-1RA therapy to those using aspirin to compare colorectal cancer incidence in each population.
Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
A 6-month tailored weight loss program helps US veterans with serious mental illness achieve significant weight reduction.
This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in ...
Jackée Harry spoke to PEOPLE about taking a GLP-1 medication for pre-diabetes. The actress lost 50 lbs. and ultimately ...
About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.
At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...
ALV-100 is a bifunctional glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist / glucagon-like peptide-1 receptor (GLP-1R) agonist fusion protein designed to address long-term ...
A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...